These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29976277)

  • 41. Impact of hydroxymethylglutaryl coenzyme A reductase inhibition on left ventricular remodeling in patients with acute anterior myocardial infarction after primary coronary angioplasty.
    Ohara Y; Hiasa Y; Hosokawa S; Miyazaki S; Ogura R; Miyajima H; Yuba K; Suzuki N; Takahashi T; Kishi K; Ohtani R
    Int Heart J; 2005 Nov; 46(6):987-95. PubMed ID: 16394594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Left ventricular torsion assessed by two-dimensional echocardiography speckle tracking as a predictor of left ventricular remodeling and short-term outcome following primary percutaneous coronary intervention for acute myocardial infarction: A single-center experience.
    Awadalla H; Saleh MA; Abdel Kader M; Mansour A
    Echocardiography; 2017 Aug; 34(8):1159-1169. PubMed ID: 28752661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of delayed opening of infarct-related artery on late left ventricular remodeling in patients with acute anterior myocardial infarction].
    Ma LK; Yu H; Huang XY; Zhu J; Feng KF; Li SG; Zhang XH; Shao ZB; Ding XM; Yan J; Gu TY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):328-31. PubMed ID: 15932662
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The predictive value of M30 and oxidative stress for left ventricular remodeling in patients with anterior ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Türkoğlu C; Gür M; Şeker T; Selek Ş; Koçyiğit A
    Coron Artery Dis; 2016 Dec; 27(8):690-695. PubMed ID: 27479531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure.
    Tousoulis D; Oikonomou E; Siasos G; Chrysohoou C; Zaromitidou M; Kioufis S; Maniatis K; Dilaveris P; Miliou A; Michalea S; Papavassiliou AG; Stefanadis C
    Atherosclerosis; 2013 Apr; 227(2):367-72. PubMed ID: 23433403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
    Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low adiponectin blood concentration predicts left ventricular remodeling after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Piestrzeniewicz K; Luczak K; Maciejewski M; Drozdz J
    Cardiol J; 2010; 17(1):49-56. PubMed ID: 20104457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Occurrence and predictors of left ventricular systolic dysfunction at hospital discharge and in long-term follow-up after acute myocardial infarction treated with primary percutaneous coronary intervention.
    Świątkiewicz I; Magielski P; Woźnicki M; Gierach J; Jabłoński M; Fabiszak T; Koziński M; Sukiennik A; Bronisz A; Kubica J
    Kardiol Pol; 2012; 70(4):329-40. PubMed ID: 22528703
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tissue plasminogen activator antigen predicts medium-term left ventricular end-systolic volume after acute myocardial infarction.
    Weir RA; Balmain S; Steedman T; Ng LL; Squire IB; Rumley A; Dargie HJ; Lowe GD
    J Thromb Thrombolysis; 2010 May; 29(4):421-8. PubMed ID: 19662337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of N-acetylcysteine on oxidative stress and ventricular function in patients with myocardial infarction.
    Yesilbursa D; Serdar A; Senturk T; Serdar Z; Sağ S; Cordan J
    Heart Vessels; 2006 Jan; 21(1):33-7. PubMed ID: 16440146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness of Atorvastatin in the Treatment of Asymptomatic Heart Failure After Myocardial Infarction: A Clinical Study.
    Wang D; Bai L; Cui XR; Yang XH; Zhang JD
    Adv Ther; 2020 Nov; 37(11):4649-4659. PubMed ID: 32968936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum levels of interleukin-6, interleukin-10 and C-reactive protein in relation to left ventricular function in patients with myocardial infarction treated with primary angioplasty.
    Karpiński L; Płaksej R; Kosmala W; Witkowska M
    Kardiol Pol; 2008 Dec; 66(12):1279-85. PubMed ID: 19169974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.
    Yasuda S; Miyazaki S; Kinoshita H; Nagaya N; Kanda M; Goto Y; Nonogi H
    Clin Sci (Lond); 2007 Jan; 112(1):43-9. PubMed ID: 16939410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of late administration of tissue-type plasminogen activator on left ventricular remodeling and function after myocardial infarction.
    Bonaduce D; Petretta M; Villari B; Breglio R; Conforti G; Montemurro MV; Lanzillo T; Morgano G
    J Am Coll Cardiol; 1990 Dec; 16(7):1561-8. PubMed ID: 2123907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive utility of the changes in matrix metalloproteinase-2 in the early phase for left ventricular reverse remodeling after an acute myocardial infarction.
    Morishita T; Uzui H; Mitsuke Y; Arakawa K; Amaya N; Kaseno K; Ishida K; Nakaya R; Lee JD; Tada H
    J Am Heart Assoc; 2015 Jan; 4(1):e001359. PubMed ID: 25616975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction.
    Wagner DR; Delagardelle C; Ernens I; Rouy D; Vaillant M; Beissel J
    J Card Fail; 2006 Feb; 12(1):66-72. PubMed ID: 16500583
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human recombinant-B-type natriuretic peptide protect ventricular function and structure in ST-elevation myocardial infarction.
    Gong X; Mou Z; Shao L; Zou Y; Gu Y; Sun S
    Int J Clin Exp Pathol; 2015; 8(9):11622-8. PubMed ID: 26617900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of combination therapy with perindopril and losartan on left ventricular remodelling in patients with myocardial infarction.
    Li L; Liu RY; Zhao XY; Zhang JY; Jia M; Lu PQ
    Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):704-10. PubMed ID: 19207720
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of different serum biomarkers for left ventricular remodelling after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Urbano-Moral JA; Lopez-Haldon JE; Fernandez M; Mancha F; Sanchez A; Rodriguez-Puras MJ; Villa M; Lopez-Pardo F; Diaz de la Llera L; Valle JI; Martinez A
    Heart; 2012 Aug; 98(15):1153-9. PubMed ID: 22572051
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum C-reactive protein elevation in left ventricular remodeling after acute myocardial infarction--role of neurohormones and cytokines.
    Takahashi T; Anzai T; Yoshikawa T; Maekawa Y; Asakura Y; Satoh T; Mitamura H; Ogawa S
    Int J Cardiol; 2003 Apr; 88(2-3):257-65. PubMed ID: 12714206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.